Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
Not Confirmed
Not Confirmed
01-03 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Industry Trade Show
Not Confirmed
01-03 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
26 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/26/3139203/0/en/PharmaTher-Provides-Corporate-Update-Following-FDA-Approval-of-Ketamine-KETARx.html
14 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/14/3133406/0/en/PharmaTher-Founder-and-CEO-Issues-Letter-to-Shareholders-following-the-FDA-Approval-of-Ketamine-KETARx.html
11 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/11/3130994/0/en/PharmaTher-Announces-FDA-Approval-of-Ketamine-KETARx.html
02 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/02/3109115/0/en/PharmaTher-Announces-Path-to-Ketamine-Commercialization-with-No-Planned-Financing-Confirms-FDA-Approval-Goal-Date-of-August-9th-2025-for-Ketamine.html
24 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/24/3104168/0/en/PharmaTher-Secures-Key-US-Patent-for-Ketamine-in-Amyotrophic-Lateral-Sclerosis-ALS-Bolstering-its-Orphan-Drug-Designated-Program-and-Targeting-a-Billion-Dollar-Market.html
18 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/18/3101393/0/en/PharmaTher-Applauds-FDA-s-New-Commissioner-s-National-Priority-Voucher-CNPV-Program-Citing-Potential-to-Accelerate-its-Ketamine-Programs-for-Mental-Health-Pain-and-Neurological-Dis.html
ABOUT THIS PAGE